About: A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) article scientifique publié en 2012 (fr) наукова стаття, опублікована в жовтні 2012 (uk)
publication date	wds:Q58286118-2763E25A-C950-4064-99F8-FE744374D42D
publication date	2012-10-01 00:00:00Z (xsd:dateTime)
cites work	wds:Q58286118-014C92F7-454C-43A8-9D34-8A3622F0F82D wds:Q58286118-1528A7EC-80D1-4942-992A-DEDF09733F3A wds:Q58286118-19A1385A-F9C5-4A17-9B8F-4D16A3F821B9 wds:Q58286118-1FF90FA1-EFE7-4BBA-A34D-FCD25D04245A wds:Q58286118-2BF91C06-118C-4E28-AA81-4ACBB889743C wds:Q58286118-2F05579E-36D3-4B82-B0EC-04F8433E92EA wds:Q58286118-34D1C0C7-BEA3-48BE-80D7-74787DF19E04 wds:Q58286118-37A9C749-D362-475F-AFBA-54E34B742CDC wds:Q58286118-39A70B8C-E6B4-467B-BF90-CABB31788BC2 wds:Q58286118-3BBC35A3-944A-4A09-AED9-76C5AE929A8A wds:Q58286118-3D6F9FCC-2990-47B2-ACEA-FFB0C64DA4D2 wds:Q58286118-3FF9ABAC-4A38-455A-9406-EDAB9F67EEFF wds:Q58286118-5754BDA1-582C-4FBA-85FE-4429A6419A8B wds:Q58286118-5CDF63C3-2EE6-4E3F-B2E8-D18751843826 wds:Q58286118-6F76BD96-7DE6-44E1-871A-60F5501A3124 wds:Q58286118-6F8DE5B0-35F1-4DF7-B81E-83C253F59EEA wds:Q58286118-85C1D662-3CF1-4CD3-BDD6-28C136021A80 wds:Q58286118-864E449B-3A1E-4118-8D44-ACDAF474F5DF wds:Q58286118-87ACF238-0AFD-402E-BFF3-B61966C6C967 wds:Q58286118-98BBF636-2660-4AA6-A78E-D1B45A4F1AF5 wds:Q58286118-9C3A1077-8646-4EEA-88E2-67412A5B40E0 wds:Q58286118-9D167921-3041-494F-B32C-8630A0214541 wds:Q58286118-9F0D3015-D51D-42FD-8697-7CF1D12C14D3 wds:Q58286118-A152F533-6AA5-45BE-AF07-A2282FE6CB18 wds:Q58286118-A25708DA-7E63-47A1-BCD5-06DADDC64330 wds:Q58286118-A6F2B4C0-C9A8-451D-B6CA-FB60A6BDFB97 wds:Q58286118-AE40E0B6-4C91-4C3C-83CE-36EE610245A6 wds:Q58286118-B18874B4-CB9F-4DC0-9F5F-73693ED0DE9E wds:Q58286118-B1A9AAA7-76AA-4F35-A80F-C0C26C230154 wds:Q58286118-B485A40C-AE75-40EF-9213-6177A7F8C376 wds:Q58286118-BF24BE5C-B641-4254-AB31-2ED86384C93F wds:Q58286118-C120D169-1377-48D5-9091-1EA251232CC8 wds:Q58286118-C29FD28A-134A-432D-8FF8-A702A2225A8A wds:Q58286118-D04457C6-13A2-4FBC-8C24-9CB170CEA100 wds:Q58286118-D786C778-0B44-4AF7-A569-5C7ED2A135B1 wds:Q58286118-DCFF743C-B72D-4854-BF80-FE26975E72F7 wds:Q58286118-EAFE6FD2-3449-41C5-89FE-1D1534D6AB2F wds:Q58286118-F3A13266-D1B3-4E00-9D67-BB6E2ECED015
cites work	Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996–2006 Pneumococcal Conjugate Vaccine, Polysaccharide Vaccine, or Both for Adults? We’re Not There Yet Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55–74 years living in Alaska: No evidence of hyporesponsiveness☆☆☆ Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits Why it is still important that countries know the burden of pneumococcal disease Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008) Serotype-specific problems associated with pneumococcal conjugate vaccination Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults Cost of pneumococcal infections and cost-effectiveness analysis of pneumococcal vaccination at risk adults and elderly in Turkey Alternative strategies for adult pneumococcal polysaccharide vaccination: a cost-effectiveness analysis. Economic Evaluation of Standing Order Programs for Pneumococcal Vaccination of Hospitalized Elderly Patients Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan Cost-effectiveness of dual influenza and pneumococcal vaccination in 50-year-olds Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions Invasive pneumococcal disease in adults in North-Rhine Westphalia, Germany, 2001-2003. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study Revaccination with a 23‐Valent Pneumococcal Polysaccharide Vaccine Induces Elevated and Persistent Functional Antibody Responses in Adults Aged ⩾65 Years Cost-benefit analysis of pediatric cochlear implantation: German experience. [Long-term follow-up of bacterial meningitis - sequels in children and adults: incidence, type, and assessment issues]. [Epidemiology of acute bacterial meningitis in adult patients in France].
author name string	wds:Q58286118-6E420E32-41C6-4092-8BA0-CD874993B09D wds:Q58286118-BF94C82C-5D92-4E06-86DF-3AA32A635DA7 wds:Q58286118-C2B020B9-D122-4AA3-8F1A-240714E65F15 wds:Q58286118-D155F119-71EA-466D-BD72-13D5032FC5C4 wds:Q58286118-D291D441-6D3D-416C-A9D0-1FB460976DAA wds:Q58286118-F6E91C22-E527-4394-AEAE-90613DBB82CF
author name string	Aline Gauthier Lieven Annemans Mark van der Linden Yiling Jiang Xavier Bresse Laurence Nicolas-Spony
rdfs:label	A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany (en) A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany (nl)
skos:prefLabel	A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany (en) A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany (nl)
name	A public health and budget impact analysis of vaccinating at-risk adults and the elderly against pneumococcal diseases in Germany (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software